why choose us

First received: August 15, 2022

Clinical Trial: A Study of the Absorption, Metabolism, and Excretion of [14C]-Fosgonimeton (ATH-1017)

Study Status: Active, not recruiting

Recruit Status: Active, not recruiting

Condition: Healthy Volunteers

Study Type: Interventional


Official Title: A Phase 1, Open-label Study of the Absorption, Metabolism, and Excretion of [14C]-Fosgonimeton (ATH-1017) Following a Single Subcutaneous Dose in Healthy Male Subjects

Brief Summary: This is a Phase 1, open-label, nonrandomized, single-dose human, absorption, metabolism, and excretion study of [14C]-Fosgonimeton

Read more